Concerns as hearts `skip a beat' in romidepsin trial

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1552, 2006-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase III Trial of Eprotirome: Discontinued for Safety Concerns

By Sweetlove Mel  

Pharmaceutical Medicine, Vol. 26, Iss. 3, 2012-06 ,pp. : 185-187

Adis International

Access to resources Recommend Favorite

Concerns raised over potential Phase 0 trial impacts

By  

Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Romidepsin: In the Treatment of T-Cell Lymphoma

By Yang Lily P.H.  

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1469-1480

Adis International

Access to resources Recommend Favorite

Romidepsin: a novel histone deacetylase inhibitor for cancer

By Bertino Erin M   Otterson Gregory A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1151-1158

Informa Healthcare

Access to resources Recommend Favorite

No Beneficial Effects of Isocolloidoosmotic Synthetic Colloid Addition to St. Thomas Hospital Cardioplegic Solution in Ischemia-Reperfusion Injury in Isolated Perfused Rat Hearts - A randomized trial

By Suzer O.   Koseoglu S.   Han G.  

General Pharmacology, Vol. 32, Iss. 1, 1999-01 ,pp. : 101-105

Elsevier

Access to resources Recommend Favorite